Carp Fine Chem Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 24-10-2024
- Paid Up Capital ₹ 0.51 M
as on 24-10-2024
- Company Age 38 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.94 Cr
as on 24-10-2024
- Revenue 1230.81%
(FY 2023)
- Profit 472.85%
(FY 2023)
- Ebitda 71.19%
(FY 2023)
- Net Worth 2.85%
(FY 2023)
- Total Assets 97.09%
(FY 2023)
About Carp Fine Chem
The Corporate was formerly known as Maneksha Pharmachem Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.51 M.
The company currently has active open charges totaling ₹3.94 Cr.
Manish Purecha and Prasahant Purecha serve as directors at the Company.
- CIN/LLPIN
U24239MH1987PTC042164
- Company No.
042164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Carp Fine Chem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasahant Purecha  | Director | 12-Nov-2004 | Current |
| Manish Purecha | Director | 12-Nov-2004 | Current |
Financial Performance of Carp Fine Chem.
Carp Fine Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1230.81% increase. The company also saw a substantial improvement in profitability, with a 472.85% increase in profit. The company's net worth moved up by a moderate rise of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carp Fine Chem?
In 2023, Carp Fine Chem had a promoter holding of 77.80% and a public holding of 22.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sonal Plasrub Industries Private LimitedActive 37 years 6 monthsManish Purecha and Prasahant Purecha are mutual person
- Shobhana Organics Private LimitedActive 22 years 1 month
Manish Purecha and Prasahant Purecha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Aug 2022 | ₹3.85 Cr | Open |
The Maharashtra State Financial Corpn. Creation Date: 04 Dec 1987 | ₹0.91 M | Open |
How Many Employees Work at Carp Fine Chem?
Carp Fine Chem has a workforce of 27 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carp Fine Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carp Fine Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
